Share this

References:

  1. Food and Drug Administration. Center for Biologics Evaluation and Research (CBER). CBER clinical review of studies submitted in support of licensure
    of ProQuad. https://www.fda.gov/media/165978/download. Accessed July 2026.
  2. World Health Organization. Measles deaths down 88% since 2000, but cases surge. accessed July 2026. https://www.who.int/news/item/28-11-2025-
    measles-deaths-down-88–since-2000–but-cases-surge?.
  3. World Health Organization. Measles reported cases and incidence. Accessed July, 2026. https://immunizationdata.who.int/global/wiise-detailpage/
    measles-reported-cases-and-incidence.
  4. World Health Organization. Measles. key facts. Accessed June, 2026.https://www.who.int/news-room/fact sheets/detail/measles?
  5. Lo NC, Hotez PJ. Public health and economic consequences of vaccine hesitancy for measles in the United States.JAMA Pediatr. 2017;171(9):887–892.
    doi:10.1001/jamapediatrics.2017.1695
  6. Ghebrehewet S, Thorrington D, Farmer S,Kearney J, Blissett D, McLeod H, Keenan A. The economic costs of measles: Healthcare, public health and
    societal costs of the 2012-13 outbreak in Merseyside, UK. Vaccine. 2016;34(15):1823–1831. doi:10.1016/j.vaccine.2016.02.029
  7. Pike J,Tippins A, Nyaku M, Eckert M, Helgenberger L, Underwood JM. Cost of a measles outbreak in a remote island economy:2014 Federated States
    of Micronesia measles outbreak. Vaccine. 2017 Oct 13;35(43):5905–5911. doi:10.1016/j.vaccine.2017.08.075
  8. Wallace AS, Masresha BG, Grant G, et al. Evaluation of economic costs of a measles outbreak and outbreak response activities in Keffa Zone, Ethiopia.
    Vaccine. 2014;32(35):4505–4514.doi:10.1016/j.vaccine.2014.06.035
  9. Wichmann O, Siedler A, Sagebiel D, et al. Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation.
    Bull World Health Organ. 2009;87(2):108–115.doi:10.2471/BLT.07.050187
  10. Suijkerbuijk AW, Woudenberg T, Hahné SJ, et al. Economic costs of measles outbreak in the Netherlands, 2013–2014. Emerg Infect Dis.
    2015;21(11):2067–2069. doi:10.3201/eid2111.150410
  11. de Soárez PC, Rozman LM, Fonseca TS, et al. Economic burden of measles outbreaks: a costof-illness study in a middle-income country in the
    post-elimination era. Rev Panam Salud Publica. 2024;48:e103. doi:10.26633/RPSP.2024.103

AE-QDX-00012 | Exp: 25 July 2028